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Abstract
Background: Khaya grandifoliola (Meliaceae) and Entada africana (Fabaceae) are traditionally used in Bamun
(a western tribe of Cameroon) traditional medicine for the treatment of liver related diseases. In this study, the
synergistic hepatoprotective effect of respective active fractions of the plants were investigated against
paracetamol-induced toxicity in primary cultures of rat hepatocytes.
Methods: Paracetamol conferred hepatocyte toxicity, as determined by the 3-(4,5-dimethylthiazol-2-yl)
-2,5-diphenyltetrazolium (MTT) assay, alanine aminotransferase (ALT), superoxide dismutase (SOD), catalase (CAT)
activities, malondialdehyde (MDA) and glutathione (GSH) content assays. The crude extracts were fractionated by
flash chromatography and fractions were tested for hepato-(protective and curative) activities. The most active
fractions of both plants were tested individually, and in combination based on their respective half effective
concentration (EC50).
Results: The methylene chloride/methanol fractions of K. grandifoliola (75:25 v/v) (KgF25) and E. africana (90:10 v/v)
(EaF10) were found to be the most hepato-protective with EC50 values of 10.30 ± 1.66 μg/ml and 13.47 ± 2.06 μg/ml
respectively, comparable with that of silymarin (13.71 ± 3.87 μg/ml). These fractions and their combination significantly
(P <0.05) improved cell viability, inhibited ALT leakage and MDA formation, and restored cellular CAT, SOD activities
and GSH content. The combination was more effective in restoring biochemical parameters with coefficients of drugs
interaction (CDI) less than 1.
Conclusion: These findings demonstrate that the active fractions have synergistic action in the protection of rat
hepatocytes against paracetamol-induced damage and suggest that their hepatoprotective properties may be
maximized by using them in combination.
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Background
Liver cirrhosis and drug-induced liver injury are the
ninth leading cause of death in western and developing
countries [1]. Although paracetamol is a safe analgesic
and antipyretic at therapeutically dose, an overdose of
the drug is associated with the development of toxic
hepatitis [2, 3]. Oxidative stress is a prominent feature in
the pathophysiology of liver disease and its conse-
quences include oxidation of cellular macromolecules
such as proteins and lipids leading to damages which are
potential for cell death [4, 5]. Once this process is initi-
ated, there is a continuous cycle of cellular damage and
release of proinflammatory cytokines resulting in hepatic
inflammation, fibrosis and cirrhosis [6].
In the search of new treatments that are more effi-
cient, less toxic and able to protect the liver against
harmful consequences of hepatic damage, medicinal
plants are important sources [7]. It is the case of Khaya
grandifoliola (Meliaceae) and Entada africana (Mimosa-
ceae), two plants used in Cameroonian traditional medi-
cine against liver related affections [8]. Pharmacological
and phytochemical studies conducted on these plants
have been reported [9]. Recently, the strong antioxidant
and cytoprotective properties of both plants were ob-
served by our research group [10].
Considering the complex pathophysiology of the liver
injury, a multi-targeting agent or a combination of
agents targeting oxidative stress, inflammation and hav-
ing hepatoprotective action would be required for preven-
tion and/or treatment of the disease. Since plants contain
various active compounds acting differently, we hypothe-
sized that the combination of the active fractions of K.
grandifoliola and E. africana would be highly effective in
preventing and treating liver injury. Thus, the present in-
vestigation examined the capacity of some combinations of
selected active fractions of the plants to protect rat’s hepa-
tocytes against toxicity induced by paracetamol.
Methods
Animals and reagents
Healthy adult Wistar albino rats of both sexes were used
in this study. The animals were housed in plastic cages
bred in the animal house of the Department of Biochem-
istry (University of Yaounde I), and placed on a semi-
synthetic diet (LAVANET, Bockle, Cameroon) with ac-
cess to the tap water ad libitum. All reagents used in this
study were of analytical grade and purchased from
Sigma Chemicals Company (Hambourg, Germany) and
Prolabo (Paris, France).
Plant material collection and preparation of the crude
extracts and fractions
Stem bark of the plants were collected in June 2012 in
Foumban (West Cameroon). The botanical identification
of the plants was done at the Cameroon National Herb-
arium, where voucher specimens were kept under the
reference numbers 23434 YA for K. grandifoliola and
52661 YA for E. africana. The extracts and fractions
were prepared as previously described [11]. The col-
lected plant materials were washed with distilled water,
air-dried, ground and sieved through a sieve of 250 μm
of diameter. Five hundred g of each powder obtained
were extracted by maceration at room temperature with
2 L of methylene chloride/methanol solvent system (1:1,
v/v) during 48 h. Each suspension was filtered using
Whatman paper N°1 and the resulting filtrate was con-
centrated under reduced pressure using a rotary evapor-
ator to yield a crude extract, 47 g of brown residue and
73 g of dark residue, respectively for E. africana and K.
grandifoliola. A portion of each crude extract (45 g for
E. africana and 70 g for K. grandifoliola) was separately
fractionated by flash chromatography over silica gel (70–
230 mesh, Merck) by eluting with a gradient of increas-
ing polarity in the methylene chloride/methanol solvent
system 100:0 v/v to 0:100 v/v; resulting in the collection
of five fractions. Solvent was eliminated as described
above and the fractions were labeled EaFc or KgFc
(methylene chloride/methanol 100:0, v/v), EaF5 or KgF5
(methylene chloride/methanol 95:5, v/v), EaF10 or KgF
10 (methylene chloride/methanol 90:10, v/v), EaF25 or
KgF25 (methylene chloride/methanol 75:25, v/v) and
EaFm or KgFm (methylene chloride/methanol 0:100, v/
v) and kept in tightly closed glass containers and stored
at −20 °C until use. Designation: EaF = Fraction of E. af-
ricana and KgF = Fraction of K. grandifoliola. The chem-
ical profile of these fractions indicates the presence of
sugar, tannins and polyphenols as major class of phyto-
chemical compounds [10].
Preparation and cultivation of hepatocytes
The rats were anesthetized using ketamine at the dose of
87.5 mg/kg of body weight and hepatocytes were isolated
in situ by liver perfusion with collagenase according to the
protocol described by Gandin et al. [12]. Hepatocytes were
washed and suspended in Dubelcco’s Modifield Eagle’s
Medium (DMEM) supplemented with glutamine (2 mM),
NaHCO3 (0.5 g/l), penicillin (100 IU/ml), streptomycin
(100 μg/ml), fungizon (5 μg/ml) and 10 % fetal bovine
serum. Cell viability was estimated immediately after isola-
tion by trypan blue exclusion test [13]. The yield of hepa-
tocytes isolation was 8.22 ± 2.69 × 106 cells/g of liver and
cells viability percentage of 83.66 ± 8.73. After isolation,
the hepatocytes were suspended in the culture medium
(DMEM) at the concentration of 0.5× 106 viable cells/ml.
Cells treatment
The plant samples, silymarin and paracetamol were diluted
in dimethyl sulfoxide (DMSO). Hepatocyte suspensions
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(approximatively 0.5.106 cells/ml) in triplicate were distrib-
uted into eppendorf 1.5 ml tubes labeled as control,
toxicant, standard and test (test sample + toxicant). In
control and toxicant tubes was added 10 μl of DMSO
and paracetamol, respectively. Contents of tubes were
homogenized and incubated at 37 °C into a CO2 in-
cubator (5 % CO2, 95 % air) and, cell viability and
membrane integrity were measured.
Determination of the toxic concentration of paracetamol
Into 990 μl of cells suspension, 10 μl of paracetamol was
added to achieve the respective final concentrations of
2.5; 5; 10; 15; 20; 25; 30 and 40 mM. The mixture was in-
cubated for 6 h and the half lethal concentration (LC50)
determined and used as toxic concentration of the drug.
The tubes were centrifuged (720 × g, 5 min, 4 °C) and ali-
quots of supernatants were used for biochemical analyses.
Hepato-(protective/curative) activity screening of plant
fractions
The plant fractions and silymarin were tested at the final
concentration of 200 μg/ml in pre-treatment (protective)
and in post-treatment (curative). In pre-treatment test,
10 μl of the sample was added to 980 μl of cellular sus-
pension and incubated for one hour. The mixture was
then intoxicated by the addition of 10 μl of paracetamol
at the predetermined toxic concentration and incubated
again for 6 h. In post-treatment test, cells were incu-
bated in the presence of the toxicant for 1 h before the
addition of 10 μl of the plant fraction or silymarin. The
tubes were centrifuged (720 × g, 5 min, 4 °C) and ali-
quots of supernatants were used for biochemical assays.
Study of hepatoprotective and synergistic effect of the
most active plant fractions
The most active plant fractions and silymarin were
tested at the final concentrations of 0.1; 1; 10; 100 and
1000 μg/ml in the pretreatment study as described
above. In synergistic studies, the most active plant frac-
tion of both plants were combined as indicated in
Table 1 based on their predetermined half efficient con-
centration (EC50). Two series of tubes were constituted,
one for assessing the effects of different combinations
on hepatocytes membrane integrity and the other on
some components of the cellular protection system. At
the end of incubation, cells were fragmented by freezing
at −20 °C and defrosted at 25 °C. The tubes were centri-
fuged (4500 × g, 20 min, 4 °C) and aliquots of superna-
tants were used for biochemical analyses.
Biochemical assays and analysis of the interaction between
the most active fractions
Cell viability
Cell viability of rat hepatocytes was measured by the 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
(MTT) assay as described by Monsees et al. [14]. After
incubation, cells were washed with 500 μl of phosphate-
buffer saline and 300 μl of MTT dissolved in PBS at a
concentration of 0.5 mg/ml was added to the cell cul-
tures. After 1h30min of incubation, each of the tube was
centrifuged (720xg, 4 ° C, 5 min) and the MTT solution
removed from the tubes by aspiration and the remaining
formazan crystals were dissolved with 300 μl of acidified
isopropanol. Optical density was read using a microplate
reader (Microreader V-320) at 560 nm. The percentage
of viability was calculated for the IC50 determinations.
Table 1 Protocol of treatment of hepatocytes in synergistic studies








I 980 10 10 10 EC50 EaF10
II 980 10 10 10 EC50 KgF25
III 980 10 10 10 EC50 EaF10 + 1 EC50 KgF25
IV 980 10 10 10 EC50 EaF10 + 3 EC50 KgF25
V 980 10 10 10 EC50 EaF10 + 5 EC50 KgF25
VI 980 10 10 10 EC50 KgF25 + 1 EC50 EaF10
VII 980 10 10 10 EC50 KgF25 + 3 EC50 EaF10
VIII 980 10 10 10 EC50 KgF25 + 5 EC50 EaF10
IX 980 10 10 10 EC50 KgF25 + 10 EC50 EaF10
silymarin 980 10 10 10 EC50 silymarin
paracetamol 990 0 10 0
control 990 0 10 0
EC50: half efficient concentration; KgF25: methylene chloride/methanol (75:25 v/v) fraction of K. grandifoliola; EaF10: methylene chloride/methanol (90:10 v/v)
fraction of E. africana. EC50 values are: 13.47 ± 2.06, 10.30 ± 1.66 and 13.71 ± 3.87 μg/ml for EaF10, KgF25 and silymarin, respectively. 10 EC50 EaF10, 10 EC50 KgF25
and 10 EC50 sil mean the fractions EaF10, KgF25 and silymarin have been tested at the final concentration of 130 μg/ml (10 × 13 μg/ml = 130 μg/ml), 100 μg/ml
(10 × 10 μg/ml = 100 μg/ml) and 130 μg/ml (10 × 13 μg/ml = 130 μg/ml), respectively
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Cell viability in each test group and toxicant group was
expressed as percentage of the control group. Cells in
control group were considered to be 100 % viable.
Cell plasma membrane integrity assessment
Hepatocytes plasma membrane integrity was assessed by
measuring the enzyme Alanine Aminotransferase (ALT)
activity in the medium according to Reitman and Frankel
[15]. Briefly, 360 μl of ALT substrate (phosphate buffer
0.1 M pH 7.4 containing 0.2 M L-alanine and 2 mM α-
ketoglutarate) was added to 40 μl of cellular supernatant.
The mixture was homogenized and maintained at 37 °C
for 30 min. Then 200 μl of 2,4-Dinitrophenyl hydrazine
solution was added and the mixture maintained at room
temperature for 20 min. Finally, 2 ml of 0.4 M NaOH was
added and the optical density was read 30 min later at
505 nm (SHIMADZU-UV-120-01). ALT activity was de-
termined by using the standardization curve established
with sodium pyruvate.
Lipid peroxidation was also assessed and the formation
of malondialdehyde (MDA) in the cells was measured by
the thiobarbituric acid (TBA) method described by Wil-
bur et al. [16]. Briefly, 500 μl of cellular supernatant,
100 μl of Triton X-100 solution (0.2 % Triton X-100 v/
v in phosphate buffer saline), 125 μl of tricholroacetic
acid (20 % w/v), and 500 μl of TBA (0.67 % w/v) were
mixed. The mixture obtained was heated at 100 °C for
20 min in a boiling water bath. After cooling for 5 min
in cold water, the mixture was centrifuged (4000 × g,
15 min, 4 °C). Finally, absorbance of supernatant col-
lected was taken at 532 nm. MDA concentration was
determined by using molar extinction coefficient
(εMDA = 1.56 × 10
5 M−1.Cm−1).
Cellular proteins content measurement
Cell proteins content was assayed according to Bradford
[17]. Briefly, 100 μl of cellular supernatant was added to
2 ml of Bradford’s reagent (0.01 g of Coomassie brilliant
blue G-250; 4.7 ml of ethanol 95°; 5.85 ml of orthophos-
phoric acid 85 % and 89.45 ml of distilled water). The
mixture was homogenized and maintained at room
temperature for 10 min and the optical density was read
at 595 nm. The protein concentration was determined
by using the standardization curve established with bo-
vine serum albumin.
Catalase (CAT) activity measurement
CAT activity was assayed according to Clairbone [18].
Briefly, 1 ml of phosphate buffer (0.1 M; pH 7.2) was
added to 975 μl of hydrogen peroxide (0.091 M) solution
and 25 μl of cellular supernatant was added. Absorbance
of the mixture obtained was taken at 560 nm each mi-
nute for 2 min. The CAT activity was calculated by using
the following formula:
Activity (UI/min/mg of protein) = (2.3033/ΔT) × (logA1/
A2)/Qprotein where A1 is the absorbance at the first mi-
nute; A2 is the absorbance at the second minute; ΔT is
the variation in time (1 min) and Qprotein is the quantity of
proteins (mg) in cellular supernatant.
Superoxide dismutase (SOD) activity measurement
SOD activity was assayed as described by Paolletti et al.
[19]. Briefly, 100 μl of cellular supernatant was added to
100 μl of mix reagent (23.12 ml of NADH 7.5 mM;
14.45 ml of the mixture EDTA 200 mM and MnCl2
100 mM v/v; and 462.4 ml of phosphate buffer 0.1 M,
pH 7.8) and 100 μl of β-mercaptoethanol (10 mM) was
quickly added to it and mixed thoroughly. The mixture
obtained was incubated at room temperature for 20 min
and the optical density was taken at 340 nm for 5 min.
The SOD activity was calculated in Unit of SOD per mg
of proteins. One unit of SOD being defined as the quan-
tity of SOD necessary to inhibit 50 % of the oxidation of
NADH to NAD+ in 5 min.
Glutathione (GSH) content measurement
Cell GSH content was assayed according to Ellman [20].
Twenty microlitres of cellular supernatant was added to
3 ml of Ellman’s reagent (0.05 mM DTNB in phosphate
buffer 0.1 M pH 6.5). After homogenization, the mixture
was maintained at room temperature for 60 min and the
optical density was read at 412 nm. The glutathione con-
centration was determined by using its molar extinction
coefficient (εGSH = 13,600 M
−1.Cm−1).
Analysis of the interaction between the most active
fractions
The coefficient of drug interaction (CDI) was used to
analyze the synergistic effect of fraction combinations
[21]. CDI is calculated as follows: CDI = AB/(A × B). AB
is the ratio of corresponding parameters of the combin-
ation groups to toxin control group. A or B is the ratio
of these parameters in the single agent groups to toxin
control group.
Statistical analysis
Data were expressed as mean ± standard deviation (SD) of
two independent assays in triplicate. The differences be-
tween the mean values of different groups were analyzed
by one-way analysis of variance (ANOVA) followed by the
Bonferroni test. Graphpad Prism version 5.0 by Windows
software was used. P < 0.05 was considered as significant.
Results
Effect of paracetamol and extracts fractions on cell
viability and ALT leakage
Incubation of hepatocytes in the presence of paraceta-
mol at a concentration range of 10–40 mM caused a
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mark decrease of cell viability (Fig. 1a) and increase of
ALT leakage (Fig. 1b) into the incubation medium after
6 h. The LC50 was found to be 13.2 ± 0.52 mM, and was
used as toxic concentration in this work. The viability of
hepatocytes and extracellular levels of ALT in the pres-
ence of the plant fractions in pre- and post-treatments
are presented in Fig. 2a and c, and Fig. 2b and d respect-
ively. Fractions EaF10 and KgF25 significantly (P <0.05)
maintained cellular viability and inhibited the leakage of
ALT from the cells; these activities were not statistically
different from that of silymarin. The above fractions, be-
ing the most active, were therefore selected for the latter
part of the study.
Effect of the most active fractions on cell viability, ALT
leakage and MDA formation
Incubation of cells with paracetamol (13 mM) for 6 h re-
sulted in a significant (P < 0.05) decrease in cell viability
(Fig. 3a), increase in ALT leakage (Fig. 3b) and MDA for-
mation (Fig. 3c) in toxicant group. When the hepatocytes
were pretreated with the plant fractions or silymarin, a
concentration-dependent protective and inhibitory effects
on cell viability, ALT leakage and MDA production was
observed. A significant (P < 0.05) effect, compared with
the paracetamol group was obtained when the plant frac-
tions were added at 100 and 1000 μg/ml. At these concen-
trations, cells viability in the test groups was not
statistically different from that of the control group and
the levels of extracellular ALT activity and MDA produc-
tion were lower. Half efficient concentrations (EC50) of
the plant fractions were found to be 10.30 ± 1.66 μg/ml,
13.47 ± 2.06 μg/ml and 13.71 ± 3.87 μg/ml for KgF25,
EaF10 and silymarin, respectively.
Effect of different combinations of the most active plant
fractions on cell viability, ALT leakage and MDA formation
Intoxication of hepatocytes with paracetamol induced
the same effects on these parameters as indicated earlier.
Cell viability percentage, ALT activity and MDA concen-
tration in the incubation medium are presented in
Table 2. The pretreatment of hepatocytes with individual
fractions at concentrations of 100 and 130 μg/ml or their
combinations significantly (P < 0.05) maintained cell via-
bility and inhibited ALT leakage and MDA formation.
Only CDI values (0.581; 0.945 and 0.995) to cellular via-
bility, ALT leakage and MDA formation, respectively of
the group “KgF25 100 μg/ml + EaF10 130 μg/ml”, as
deduced from its individual groups, were less than 1.
Moreover, the combination significantly (P < 0.05) re-
duced ALT leakage and MDA formation by 55 (Fig. 5a)
and 65 (Fig. 5b) percent, respectively.
Effect of different fraction combinations on CAT and SOD
activities, and cell GSH content
Incubation of cells with paracetamol alone or after pre-
treatment with the individual plant active fractions/com-
binations resulted in no significant variation of protein
contents (Fig. 4a). However, the CDI value of the group
“Para + KgF25 100 μg/ml + EaF10 130 μg/ml” was 0.998.
A significant (P < 0.05) decrease of the activity of CAT
(Fig. 4b), SOD (Fig. 4c) and GSH content (Fig. 4d) were
observed. Although pretreatment with individual best
fractions significantly (P < 0.05) restored the cellular
glutathione content, only some combinations signifi-
cantly (P < 0.05) increased the activity of these antioxi-
dant enzymes and the glutathione content as compared





















































Fig. 1 Effect of paracetamol concentrations on cell viability (a) and ALT leakage (b). Values are mean ± SD of two independent experiments in
triplicate. *P < 0.05, compared with control (0 mM)
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the combination of KgF25 100 μg/ml + EaF10 130 μg/
ml, yielding CDI values of 0.871; 0.986 and 0.653 for
CAT, SOD activities and glutathione content, respect-
ively. With regard to the latter parameter, the combin-
ation increased it by 2-folds (Fig. 5e).
Discussion
In the present study, we evaluated the capacity of active
fractions obtained from stem bark crude extracts of K.
grandifoliola and E. africana and their combinations to
protect primary rat hepatocytes against paracetamol-
induced toxicity. Hepatic injuries induced by paracetamol
are widely used to evaluate hepatoprotective activities of
drugs and medicinal plants [22–24]. The use of rat
hepatocytes culture reduces the number of animals sacri-
ficed for hepatoprotective activity study [25]. The toxicity
markers upon exposition of hepatocytes to a toxic dose of
paracetamol are very often transaminases (ALT and As-
partate aminotransferase), cytosolic enzymes of which
their elevation in the extracellular medium is a sign of
alteration of cell membrane integrity, while MDA concen-
tration increase indicates membrane lipid peroxidation
[26]. The hepatotoxicity induced by paracetamol is attrib-
uted to the action of N-acetyl-para-benzoquinon-imine
(NAPBQI) which results from its biotransformation by
the cytochrome P450 enzyme system. When NAPBQI
forms and is not detoxified it fixes the cellular glutathione
reserve and binds to the cellular proteins causing their
a b
c d
Fig. 2 Effects of fractions on hepatocyte viability and ALT leakage in pretreatment (a and b, respectively) and post-treatment (c and d, respectively). Values
are mean ± SD of two independent experiments in triplicate; ΔP< 0.05 compared with control group; *P < 0.05 compared with paracetamol (para)-
intoxicated group; Sil: silymarin; EaFc: methylene chloride fraction of E. africana; EaF5: methylene chloride/methanol (95:5 v/v) fraction of E.
africana; EaF10: methylene chloride/methanol (90:10 v/v) fraction of E. africana; EaF25: methylene chloride/methanol (75:25 v/v) fraction of
E. africana; EaFm: methanol fraction of E. africana; KgFc: methylene chloride fraction of K. grandifoliola; KgF5: methylene chloride/methanol
(95:5 v/v) fraction of K. grandifoliola; KgF10: methylene chloride/methanol (90:10 v/v) fraction of K. grandifoliola; KgF25: methylene chloride/methanol
(75:25 v/v) fraction of K. grandifoliola; KgFm: methanol fraction of K. grandifoliola
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Fig. 3 Effect of the most active plant fractions in pretreatment on the hepatocytes viability (a), ALT leakage (b) and lipids membrane oxidation (c). Values
are mean ± SD of two independent experiments in triplicate. aP< 0.05 compared with control group; bP< 0.05 compared with paracetamol (para)-
intoxicated group; EaF10: methylene chloride/methanol (90:10 v/v) of E. africana; KgF25: methylene chloride/methanol (75:25 v/v) fraction of K. grandifoliola
Table 2 Effects of selected fractions and their combinations on hepatocyte viability, ALT leakage and MDA formation
Groups Cell Viability (% of control) ALT Activity (UI/L) [MDA] (μM/5 × 105 hepatocytes)
Control 100.000 ± 2.600 27.830 ± 4.720 0.131 ± 0.032
paracetamol 51.520 ± 3.510** 78.660 ± 4.850** 0.517 ± 0.053**
paracetamol + silymarin (130 μg/ml) 95.200 ± 6.950* 55.330 ± 4.360* 0.282 ± 0.033*
paracetamol + EaF10 (130 μg/ml) 96.940 ± 6.350* 56.160 ± 2.510* 0.303 ± 0.045*
paracetamol + KgF25 (100 μg/ml) 96.540 ± 4.260* 55.330 ± 3.320* 0.307 ± 0.033*
paracetamol + (EaF10 130 μg/ml + KgF25 10 μg/ml) 96.850 ± 3.920* 55.500 ± 3.000* 0.290 ± 0.041*
paracetamol + (EaF10 130 μg/ml + KgF25 30 μg/ml) 99.620 ± 4.250* 54.33 ± 1.750* 0.277 ± 0.029*
paracetamol + (EaF10 130 μg/ml + KgF25 50 μg/ml) 101.050 ± 1.880* 45.330 ± 5.000* 0.264 ± 0.037*
paracetamol + (KgF25 100 μg/ml + EaF10 13 μg/ml) 97.360 ± 0.590* 54.660 ± 4.310* 0.299 ± 0.060*
paracetamol + (KgF25 100 μg/ml + EaF10 39 μg/ml) 99.760 ± 0.200* 47.500 ± 3.000* 0.273 ± 0.019*
paracetamol + KgF25 100 μg/ml + EaF10 65 μg/ml) 102.360 ± 2.290* 42.160 ± 2.080* 0.235 ± 0.029*
paracetamol + (KgF25 100 μg/ml + EaF10 130 μg/ml) 105.510 ± 2.400* (0.581) 37.330 ± 2.36* (0.945) 0.179 ± 0.013* (0.995)
Values are mean ± SD from two independent experiments in triplicate. **P < 0.05 compared with control group; *P < 0.05 compared with paracetamol (para)-
intoxicated group; EaF10: methylene chloride/methanol (90:10 v/v) fraction of E. africana; KgF25: methylene chloride/methanol (75:25 v/v) fraction of K.
grandifoliola. Numbers in brackets indicate the coefficient of drug interaction (CDI)
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inactivation. Mitochondrial dysfunction, accumulation of
the reactive oxygen species involved in lipid peroxidation,
increase of membrane permeability leading to cell death
are associated to the toxicity of this metabolite [5]. A
major defense system of hepatocytes involves the antioxi-
dant enzymes which include SOD and CAT and also anti-
oxidant molecules such as glutathione [27] which convert
the toxic reactive metabolites of xenobiotic biotransform-
ation into non-toxic compounds. The enzymes of the
defense system are natural protector against lipid peroxi-
dation [28]. These enzymes prevent generation of hy-
droxyl radical and protect cellular constituents from
oxidative damage.
In this study, paracetamol was used at determined
concentration of 13 mM. This concentration was found
to be toxic for 6 h exposition of hepatocytes leading to
about 50 % decrease of cells viability and great increase
of ALT leakage. This indicates a loss of hepatocytes
membrane integrity and MDA formation evidencing
oxidation of lipid membrane. A significant (P < 0.05) de-
crease in CAT, SOD activities and GSH content was also
observed as consequence of production and accumula-
tion of paracetamol reactive metabolites and reactive
oxygen species (ROS).
In both pre-and post-treatments tests, the plant frac-
tions (KgF25 and EaF10) at 200 μg/ml significantly (P <
0.05) maintained cell viability and inhibited the release
of ALT into the incubation medium. Likewise, pretreat-
ment of hepatocytes with these most active plant frac-
tions/combination at concentrations of 100 and 130 μg/
ml, respectively, showed a significant (P < 0.05) decrease
in MDA formation, maintained cell viability and inhib-
ited ALT leakage. These results suggest that the fractions/
combination were/was able to stabilize membrane integ-
rity and inhibit membrane lipid peroxidation. Lipid oxida-
tion being a mechanism of paracetamol-induced damage
in cell membrane [29], it is possible that the inhibition of








































































































































Fig. 4 Effects of the most active plant fractions and their combinations on protein contents (a), catalase (b) and SOD (c) activities and glutathione
content (d). Values are mean ± SD of two independent experiments in triplicate. ΔP < 0.05 compared with control group; *P < 0.05 compared with
paracetamol (para)-intoxicated group. C: control group; P: Paracetamol intoxicated group; S: Para + silymarin (130 μg/ml) group; I: Para + EaF10
(130 μg/ml) Group; II: Para + KgF25 (100 μg/ml) Group; III: Para + (EaF10 130 μg/ml + KgF25 10 μg/ml) Group; IV: Para + (EaF10 130 μg/ml + KgF25
30 μg/ml) Group; V: Para + (EaF10 130 μg/ml + KgF25 30 μg/ml) Group; VI: Para + (KgF25 100 μg/ml + EaF10 13 μg/ml) Group; VII: Para + (KgF25
100 μg/ml + EaF10 39 μg/ml) Group; VIII: Para + (KgF25 100 μg/ml + EaF10 65 μg/ml) Group; IX: Para + (KgF25 100 μg/ml + EaF10 130 μg/ml) Group.
EaF10: methylene chloride/methanol (90:10 v/v) fraction of E. africana; KgF25: methylene chloride/methanol (75:25 v/v) fraction of K. grandifoliola
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by the plant fractions against toxic effects caused by para-
cetamol. Although pretreatment with individual most ac-
tive fractions significantly (P < 0.05) restored the cellular
glutathione content, only some combinations significantly
(P < 0.05) restored CAT, SOD activities and glutathione
content. Previous works [28, 30] have demonstrated that a
reduction of the activities of these enzymes is associated
with the accumulation of highly reactive free radicals, re-
active metabolites and ROS. Therefore, the fractions
might possess an antioxidative role in paracetamol-
induced generation of ROS. Interestingly, the combination
of fractions (KgF25 100 μg/ml + EaF10 130 μg/ml) was
more effective than its individual fractions in inhibiting or
restoring biochemical parameters assessed in this study
with CDI less than 1. Since CDI value less than, equal to
or greater than 1 indicates that the fractions are
synergistic, additive or antagonistic [21] respectively, it
might be suggested that the active fractions KgF25 and
EaF10 are synergistic. Njayou et al. [10] have shown that
methylene chloride/methanol extracts of E. africana and
K. grandifoliola contain polyphenols, secondary metabo-
lites known to be antioxidative and hepatoprotective [23,
31]. Thus, the activity of these fractions may be due to the
presence of such phytochemical groups of compounds.
Conclusion
The results demonstrate that the combination of the
most active respective fractions KgF25 of K. grandifoliola
and EaF10 of E. africana is more efficient than individ-
ual fractions in the protection of rat hepatocytes against
paracetamol-induced damage. Also, this study suggests



















































































































































































































Fig. 5 Effectiveness of selected fractions and their combination on ALT leakage (a), MDA formation (b), SOD (c) and catalase (d) activities and
glutathione content (e). Values are mean ± SD of two independent experiments in triplicate. *P < 0.05 compared with paracetamol (para)-
intoxicated group; P: Paracetamol-intoxicated group; I: Para + EaF10 (130 μg/ml) Group; II: Para + KgF25 (100 μg/ml) Group; IX: Para + (KgF25
100 μg/ml + EaF10 130 μg/ml) Group; EaF10: methylene chloride/methanol (90:10 v/v) fraction of E. africana; KgF25: methylene chloride/methanol
(75:25 v/v) fraction of K. grandifoliola
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be maximized by using them in combination. The in
vivo study of the best combination of these fractions is
an area for further research.
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